Business Wire

Rimini Street Announces the Immediate Availability of Comprehensive Support, Security and Consulting Services for VMware Products

20.5.2024 16:00:00 EEST | Business Wire | Press release

Share

Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, products and services, the leading third-party support provider for Oracle and SAP software, and a Salesforce and AWS partner, today announced the global launch of Rimini Support™, Rimini Protect™ and Rimini Consult™ for VMware products, in a first-of-its-kind, comprehensive third-party offering.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240520716317/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Rimini Street Announces the Immediate Availability of Comprehensive Support, Security and Consulting Services for VMware Products (Graphic: Business Wire)

Rimini Street services for VMware will allow perpetually-licensed VMware customers to continue running their current systems for years into the future – with Rimini Street’s award-winning support services that includes guaranteed priority support response by an engineer 24/7/365 in 10 minutes or less. The standard pricing for Rimini Street Support for VMware products is similar to the current support fees each perpetual licensee is paying VMware.

“Many organizations are perpetually licensed to use VMware products and are now facing significant annual fee increases demanded by VMware. These organizations are now looking for an alternative, comprehensive annual support program that can enable them to continue implementing, changing and running their perpetually licensed VMware software infrastructure smoothly and reliably for years into the future,” said Seth Ravin, CEO and president of Rimini Street. “Rimini Street is now offering such a support program for VMware products as an extension of its award-winning, mission-critical global support services utilized successfully by thousands of clients in more than 100 countries over nearly two decades.”

Buy Time and Extend the Useful Life of VMware Perpetual Licenses

Unsettled by VMware’s sudden transition to a new subscription-based licensing model with the forced bundling of licenses for products that were not previously selected, licensed or used by some VMware customers, VMware perpetual licensees need time to analyze the software vendor’s proposed changes and determine if they are going to eventually accept their new licensing model and fees, attempt to negotiate new licensing terms and fees or evaluate, select and implement a new virtualization platform. In any of these cases, selecting Rimini Support for VMware buys an organization the time - up to years - to perform this analysis and make and implement these critical infrastructure decisions while receiving Rimini Street premium support for their current, paid-for and perpetually licensed VMware infrastructure that still has years of useful life.

“Our clients have made significant investments in their current VMware infrastructure, and many are seeking advice and counsel from Rimini Street on how to both continue leveraging their mature and proven VMware infrastructure platform and get the premium, mission-critical quality support and services they need at a price point they can afford,” said Craig Mackereth, executive vice president of global service delivery at Rimini Street. “Rimini Street is now offering a unique, innovative support solution for VMware, with immediate availability.”

“Rimini Street delivers exceptional support for our current enterprise software platform. We are excited that we now have the option to extend the lifespan of our existing VMware products for years and get exceptional support for our VMware infrastructure through Rimini Street,” said Kentaro Yamamoto, general manager, IT strategy department at JSR Corporation, a Japan-based, global chemical manufacturer for semiconductors.

A Trio of Powerful, Proven Solutions, Now Available for VMware

Rimini Support™ for VMware: Premium, global 24/7/365 support and advisory services with industry-leading SLAs, and includes:

  • Dedicated support services for configuration, performance, installation, upgrade, and customization
  • A named primary support engineer with an average of 15 years of experience
  • Guaranteed 10-minute response SLA for critical cases
  • Rimini Street’s patented AI technology, Case Assignment Advisor, that empowers its engineers to resolve cases much faster by recommending the optimal engineer based on 40+ vectors

Rimini Protect™ for VMware: Proactive, fast and cost-effective security protection against known and unknown threats and vulnerabilities, and includes:

  • Guidance on mitigating risk by strengthening the configuration of VMware ecosystem
  • Rimini Street’s self-developed Security Vulnerability Analysis Reports (SVARs), intelligence reports that include mitigation options and strategies
  • Zero-day reporting
  • Level 1 Security Assessments

Rimini Consult™ for VMware: Expert consulting services to help VMware customers identify their best path forward and help align technology strategy with business objectives. Services include:

  • Technical and application roadmapping and strategy
  • Technology assessments
  • License advisory
  • Interoperability and integration
  • Staff and skills augmentation
  • Cloud migrations

“Rimini Street continues to be at the forefront of innovation by listening to the changing market needs of organizations around the world and launching new solutions and market choices that make it possible for organizations to maximize the ROI and lifespan of their current, significant IT investments and buy time to make critical go-forward infrastructure decisions,” said R “Ray” Wang, principal analyst at Constellation Research, Inc. “We’re excited to see the expansion of Rimini Street support services to include VMware products. Customers sorely need an alternative to the predatory tactics by VMware to move customers from on-premises to the cloud. Rimini Street is a proven provider of third-party enterprise software support services with extensive experience in delivering mission-critical services for nearly two decades.”

To learn more about Rimini Street’s VMware offering, click here. To get connected for an immediate consultation with one of Rimini Street’s VMware Enterprise Architects or other experts, simply email vmware@riministreet.com.

About Rimini Street, Inc.

Rimini Street, Inc. (Nasdaq: RMNI), a Russell 2000® Company, is a global provider of end-to-end enterprise software support, products and services, the leading third-party support provider for Oracle and SAP software and a Salesforce and AWS partner. The Company has operations globally and offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize enterprise application, database, and technology software, and enables clients to achieve better business outcomes, significantly reduce costs and reallocate resources for innovation. To date, over 5,500 Fortune 500, Fortune Global 100, midmarket, public sector, and other organizations from a broad range of industries have relied on Rimini Street as their trusted enterprise software solutions provider. To learn more, please visit riministreet.com, and connect with Rimini Street on Twitter, Instagram, Facebook and LinkedIn. (IR-RMNI)

Forward-Looking Statements

Certain statements included in this communication are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “anticipate,” “believe,” “continue,” “could,” “currently,” “estimate,” “expect,” “future,” “intend,” “may,” “might,” “outlook,” “plan,” “possible,” “potential,” “predict,” “project,” “seem,” “seek,” “should,” “will,” “would” or other similar words, phrases or expressions. These forward-looking statements include, but are not limited to, statements regarding our expectations of future events, future opportunities, global expansion and other growth initiatives and our investments in such initiatives. These statements are based on various assumptions and on the current expectations of management and are not predictions of actual performance, nor are these statements of historical facts. These statements are subject to a number of risks and uncertainties regarding Rimini Street’s business, and actual results may differ materially. These risks and uncertainties include, but are not limited to, adverse developments in and costs associated with defending pending litigation or any new litigation, including the disposition of pending motions to appeal and any new claims; additional expenses to be incurred in order to comply with injunctions against certain of our business practices and the impact on future period revenue and costs; changes in the business environment in which Rimini Street operates, including the impact of any recessionary economic trends and changes in foreign exchange rates, as well as general financial, economic, regulatory and political conditions affecting the industry in which we operate and the industries in which our clients operate; the evolution of the enterprise software management and support landscape and our ability to attract and retain clients and further penetrate our client base; significant competition in the software support services industry; customer adoption of our expanded portfolio of products and services and products and services we expect to introduce; our ability to sustain or achieve revenue growth or profitability, manage our cost of revenue and accurately forecast revenue; estimates of our total addressable market and expectations of client savings relative to use of other providers; variability of timing in our sales cycle; risks relating to retention rates, including our ability to accurately predict retention rates; the loss of one or more members of our management team; our ability to attract and retain additional qualified personnel, including sales personnel, and retain key personnel; challenges of managing growth profitably; our need and ability to raise additional equity or debt financing on favorable terms and our ability to generate cash flows from operations to help fund increased investment in our growth; risks associated with global operations; our ability to prevent unauthorized access to our information technology systems and other cybersecurity threats, protect the confidential information of our employees and clients and comply with privacy regulations; our ability to maintain an effective system of internal control over financial reporting; our ability to maintain, protect and enhance our brand and intellectual property; changes in laws and regulations, including changes in tax laws or unfavorable outcomes of tax positions we take, or a failure by us to establish adequate tax reserves; the impact of environmental, social and governance (ESG) matters; our credit facility’s ongoing debt service obligations and financial and operational covenants on our business and related interest rate risk, including uncertainty from the transition to SOFR or other interest rate benchmarks; the sufficiency of our cash and cash equivalents to meet our liquidity requirements; the amount and timing of repurchases, if any, under our stock repurchase program and our ability to enhance stockholder value through such program; uncertainty as to the long-term value of Rimini Street’s equity securities; catastrophic events that disrupt our business or that of our clients; and those discussed under the heading “Risk Factors” in Rimini Street’s Quarterly Report on Form 10-Q filed on May 2, 2024, and as updated from time to time by Rimini Street’s future Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other filings by Rimini Street with the Securities and Exchange Commission. In addition, forward-looking statements provide Rimini Street’s expectations, plans or forecasts of future events and views as of the date of this communication. Rimini Street anticipates that subsequent events and developments will cause Rimini Street’s assessments to change. However, while Rimini Street may elect to update these forward-looking statements at some point in the future, Rimini Street specifically disclaims any obligation to do so, except as required by law. These forward-looking statements should not be relied upon as representing Rimini Street’s assessments as of any date subsequent to the date of this communication.

© 2024 Rimini Street, Inc. All rights reserved. “Rimini Street” is a registered trademark of Rimini Street, Inc. in the United States and other countries, and Rimini Street, the Rimini Street logo, and combinations thereof, and other marks marked by TM are trademarks of Rimini Street, Inc. All other trademarks remain the property of their respective owners, and unless otherwise specified, Rimini Street claims no affiliation, endorsement, or association with any such trademark holder or other companies referenced herein.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Janet Ravin
VP, Global Communications
Rimini Street, Inc.
+1 702 285-3532
pr@riministreet.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz ® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 16:29:00 EET | Press release

Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “Today’s positive CHMP opinion is an important step towards addressing the urgent need for new treatment options for patients in Europe with advanced SCAC, a disease which has seen limited innovation for decades,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved, Zynyz in combination with platinum-based chemotherapy has the potential to become a new standard-of-care for patients living with this rare and difficult-to-treat cancer.” The positive CHMP opinion was based on data from the Phase 3 POD1UM-303/Inter

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 14:32:00 EET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 10:00:00 EET | Press release

With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerful, secure, reliable, and intelligent digital signage,” said Steve Durkee, chief executive office

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 09:30:00 EET | Press release

Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, supported by one of the largest bodies of published clinical data backed by decades of clinica

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 09:00:00 EET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye